2Tapson VF. Advances in the diagnosis and treatment of acute pulmo- nary embolism[J]. F1000 Med Rep, 2012,4:9.
3Kueher N, Rossi E, De Rosa M, et al. Massive pulmonary embol-ism [ J]. Circulation, 2006,113 (4) :577-582.
4Torbicki A, Pettier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology ( ESC ) [ J ]. Eur Heart J, 2008,29 (18) :2276-2315.
5Kostrubiec M, Pruszczyk P, Kaczynska A, et al. Persistent NT- proBNP elevation in acute pulmonary embolism predicts early death [J]. Clin Chim Acts, 2007,382(1-2) :124-128.
6Viswanathan K, Kilcullen N, Morrell C, et al. Heart type fatty acid-binding protein predicts long-term mortality and reinfarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative[ J ]. J Am Coll Cardiol, 2010,55 ( 23 ) : 2590- 2598.
7Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism[J]. Medicine, 2006, 85(5): 253-262.
8Konstantinides S, Kasper W. Pulmonary embolism[M]//Massie BM, Drexler H. Cardiology. London: Mosby International, 2001: 18.1-18.10.
9Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism[J]. N Engl J Med, 1992, 326(19): 1240-1245.
10Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism[J]. Lancet, 1992, 340(8824): 873-876.
